Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 87.42% vs -78.65% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 94.87% vs 0.00% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 66.67% vs -40.00% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Aspire Biopharma Holdings, Inc. With
Quarterly - Net Sales
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 87.42% vs -78.65% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -1,900.00% vs -105.56% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 94.87% vs 0.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -700.00% vs 66.67% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 66.67% vs -40.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024






